SPONSOR
The Institute of Molecular and Translational Medicine, Czech Republic
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Rectal Cancer PatientsLung CancerBronchial AsthmaPulmonary Cystic FibrosisBreast Neoplasm FemaleMetastatic Breast Cancer
The Institute of Molecular and Translational Medicine, Czech Republic is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Rectal Cancer Patients, Lung Cancer, Bronchial Asthma, Pulmonary Cystic Fibrosis.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Institute of Molecular and Translational Medicine, Czech Republic
How many clinical trials has The Institute of Molecular and Translational Medicine, Czech Republic sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by The Institute of Molecular and Translational Medicine, Czech Republic, of which 4 are actively recruiting participants. These trials cover conditions including Rectal Cancer Patients, Lung Cancer, Bronchial Asthma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Institute of Molecular and Translational Medicine, Czech Republic research focus on?
The Institute of Molecular and Translational Medicine, Czech Republic clinical trials span Rectal Cancer Patients, Lung Cancer, Bronchial Asthma, Pulmonary Cystic Fibrosis, Breast Neoplasm Female, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Institute of Molecular and Translational Medicine, Czech Republic clinical trial?
To participate in a The Institute of Molecular and Translational Medicine, Czech Republic trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Institute of Molecular and Translational Medicine, Czech Republic trials with current recruitment status updated daily.
Clinical Trials by The Institute of Molecular and Translational Medicine, Czech Republic
NCT07112937
Recruiting
The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study
Rectal Cancer Patients
NCT06016569
Recruiting
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
Lung Cancer
NCT04157361
Recruiting
Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.
Bronchial Asthma
NCT03323346 Phase 2
Recruiting
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
Breast Neoplasm Female
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology